Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease. [electronic resource]
Producer: 20020320Description: 31-40 p. digitalISSN:- 0195-668X
- Aged
- Ambulatory Care -- economics
- Coronary Artery Disease -- complications
- Cost-Benefit Analysis -- economics
- Electrocardiography -- economics
- Endpoint Determination
- Female
- Fibrinolytic Agents -- economics
- Follow-Up Studies
- Health Care Costs
- Hospitalization -- economics
- Humans
- Male
- Myocardial Infarction -- complications
- Platelet Glycoprotein GPIIb-IIIa Complex -- economics
- Prospective Studies
- Scandinavian and Nordic Countries -- epidemiology
- Sensitivity and Specificity
- Survival Analysis
- Ventricular Function, Left -- physiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.